InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (6 ops.)
Discover the detailed record of transactions filed by Svoronos Dawn, Director. Director active across 3 companies, notably PTC Therapeutics, INC.. Aggregated, 10 filings have been published. Total volume traded: €153k. The latest transaction was filed on 21 June 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations10 total
€49,3541,908 shares@ €25.8668100.0% of flow
Common Stock
SEC:0000899243-22-023597:0·
3,600 shares
Common Stock
SEC:0000899243-22-022889:0·
€18,904738 shares@ €25.61490.0003% mcap24.0% of flow
Common Stock
SEC:0001415889-22-006410:0·
€24,50230,000 shares@ €0.8167100.0% of flow
Common Stock
SEC:0001209191-22-030075:0·
Ideal exit: 10 Feb 2023 (T+270)
€17,392510 shares@ €34.10230.0003% mcap58.1% of flow
Common Stock
SEC:0001179110-22-000392·
€17,392510 shares@ €34.10230.0003% mcap22.1% of flow
Common Stock
SEC:0001179110-22-000392:0·
3,037 shares
Common Stock
SEC:0000899243-21-025001·
3,037 shares
Common Stock
SEC:0000899243-21-025001:0·
€12,550365 shares@ €34.38270.0002% mcap15.9% of flow
Common Stock
SEC:0001179110-21-006598:0·
€12,550365 shares@ €34.38270.0002% mcap41.9% of flow
Common Stock
SEC:0001179110-21-006598·
10 of 10 declarations
About Svoronos Dawn
Dawn Svoronos is a Board Member at PTC THERAPEUTICS, INC., Global Blood Therapeutics, Inc., and Adverum Biotechnologies, Inc. She brings expertise in corporate governance and strategic development. Her role is crucial in guiding board decisions and ensuring compliance with regulatory standards.
